Now Aceepting Tricare, Triwest, and Medicare for Spravato!
We’re thrilled to announce we can now treat Tricare, Triwest, and Medicare patients with Spravato—a breakthrough prescription nasal spray for treatment-resistant depression. Here are a few things everyone should know about Spravato Esketamine Nasal Spray…
- Spravato is the first and only nasal spray approved by the FDA for patients with Treatment-Resistant Depression.
- Spravato is a type of Ketamine.
- Spravato works on a different neurotransmitter than traditional antidepressants called glutamate (which can lead to increased neuroplasticity).
- If you’ve tried therapy, medication and other treatments for depression without relief, Ketamine Treatment might be right for you.
Spravato Is Covered By Most Major Insurance Companies
For patients at New U Therapy & Family Services who have expressed interest in the transformative benefits of Ketamine, this is an exciting step forward! We understand that the cost of care can be a consideration, and this expanded coverage means that more individuals can now access the benefits of Spravato treatment while utilizing their insurance coverage.
Our commitment to your well-being drives us to continually seek innovative solutions that empower you on your journey toward mental wellness. If you or someone you know has been navigating the complexities of treatment-resistant depression, we invite you to explore this innovative treatment that offers new hope and healing.
